Follow Us:
Sunday, March 29, 2020

Prabha Raghavan

Profile

Not enough ventilators, so PSUs and corporates start ramping up production
Sun, Mar 29, 2020

With the number of COVID-19 cases rising, the country might need anywhere between 1,10,000 and 2,20,000 ventilators by May 15 in the worst-case scenario, according to an analysis by think tank Brookings India.

From hours to minutes: Taking road less travelled to speed up COVID-19 test results
Sat, Mar 28, 2020

It is crucial to move beyond RT-PCR tests because they would have “very little value” in the event people with positive antibodies to the virus (meaning they have COVID-19 but their immune system has tackled the virus) are tested, according to her.

Government steps in after retailers and e-commerce players stopped
Thu, Mar 26, 2020

While some authorities including Delhi Police, Gurugram Police, Noida Police and Ahmedabad Municipal Corporation instituted mechanisms for allowing home deliveries, many raised concerns over non-adherence of Union Ministry of Home Affairs orders in different states.

Coronavirus lockdown: Drug movement disrupted, patients left in the lurch
Thu, Mar 26, 2020

Amid the lockdown, disruptions in supply of essential medicines across state borders have left patients like Sanjay in the lurch. The panic buying of certain medicines hasn’t helped either.

In a first, private lab collects sample: No point being scared
Wed, Mar 25, 2020

Around 22 private laboratories, including Dr Lal PathLabs, Dr Dangs Lab and Indraprastha Apollo have been approved to help government test patients for the virus.

Not testing enough to check community transmission: Dr Gagandeep Kang
Sun, Mar 22, 2020

India’s response system is not watertight, leaving the possibility for community transmission cases, according to Dr Gagandeep Kang, executive director of Translational Health Science and Technology Institute, an autonomous body under the Science and Technology Ministry’s Department of Biotechnology.

Stretched supply chains: Directive to Indian Missions to explore alternative API sources
Thu, Mar 19, 2020

India depends on China for nearly 70 percent of its import requirements of bulk drugs, but the Covid-19 outbreak in the neighbouring country forced it to speed up efforts to cut this dependence.

Coronavirus: Day after ICMR asks private labs to do tests free, they reach out to govt
Thu, Mar 19, 2020

Diagnosing COVID-19 for free without such relaxations may not be a viable model for these firms, as they will have to bear logistics, manpower and testing costs on their own, according to some representatives of private labs.

Explained: Five steps to detecting the coronavirus (COVID-19)
Wed, Mar 18, 2020

The process was explained to The Indian Express by Dr V Ravi, Senior Professor & Head, Department of Neurovirology, NIMHANS.

Explained: How the coronavirus (COVID-19) test works
Wed, Mar 18, 2020

How does the PCR test look for the virus in swab samples? How long does it take? How many samples is India testing daily, and can it test more? If it can, why has it not scaled up yet?

The Corona Fighters: 24/7, a CMO and his team track the virus — making endless calls, visiting many homes
Sun, Mar 15, 2020

Over the last three months, COVID-19, the illness caused by the novel coronavirus SARS-CoV-2, has taken over the lives of the CMO and his staff.

Why lethal cough syrup slipped past the law
Fri, Mar 13, 2020

Rules say maintain prescription register with patients’ details but no trace of many bottles from contaminated batch.

Behind killer cough syrup Coldbest: Glaring gaps in regulation and its manufacture
Thu, Mar 12, 2020

Over a month of investigations, first by a team of doctors from PGIMER-Chandigarh and later by drug control regulators, revealed on March 2 that the syrup was, in fact, the culprit.

Claims of drug price hikes ‘unsubstantiated’, no shortage of key ingredients: NPPA chief
Fri, Mar 06, 2020

NPPA on Thursday evening also stated in a tweet that it has asked the Himachal Pradesh drug controller to “take notice” of reported problems faced by pharmaceutical companies in Baddi and “act immediately to ensure uninterrupted availability of APIs.”

Daily review of export curb on paracetamol, Vitamin B12, other constituents being done: DoP Secy
Fri, Mar 06, 2020

China accounts for nearly 70 per cent of India’s total imports of raw drug materials like active pharmaceutical ingredients (APIs) and the key ingredients used to make them (KSMs).

Countering supply disruption: DoP panel for tax holidays, incentives to cos producing key drug ingredients
Thu, Mar 05, 2020

The committee wants the government to prioritise those APIs and KSMs (key starting materials) for which India is heavily dependent on imports when granting these incentives.

Look for therapeutic alternatives to crucial constituents: Panel to ICMR
Thu, Mar 05, 2020

The development comes after an earlier exercise by the council to zero in on alternatives that could keep the country from running out of crucial stocks of various painkillers, antibiotics, antidiabetic and cardiovascular medicines as well as vitamins, The Indian Express has learnt.

China shuttered, India curbs exports to stock key drug ingredients
Wed, Mar 04, 2020

According to the directorate’s notification, the export of 13 such active pharmaceutical ingredients (APIs) and medicines made from them, have been restricted.

All international passenger arrivals on watchlist as coronavirus cases rise
Wed, Mar 04, 2020

GoI has also decided to suspend with immediate effect all regular visas and e-visas issued to nationals of Italy, Iran, South Korea and Japan issued on or before March 3 and have not entered India yet.

Amid rising COVID-19 cases, panel formed to boost production of key drug ingredients
Wed, Mar 04, 2020

The present stock of active pharmaceutical ingredients (API) "may be sufficient" for 2-3 months to make formulations, the Department of Pharmaceuticals (DoP) has said.

Advertisement
Advertisement
Advertisement
Advertisement